# new trial (audio feeds) — RSS Amplifier

Recent posts from the 1 feeds in the RSS Amplifier directory that cover new trial.

Page: <https://rssamplifier.com/topics/new-trial/audio>  
Feed: <https://rssamplifier.com/topics/new-trial/audio.md>

---

## [New in Oncology - Aug 13, 2026](https://sagelyhealth.substack.com/p/new-in-oncology-aug-13-2026)

_2026-08-13 · Oncology Intel by Sagely Health_

Catching resistance early, pushing remission deeper: ctDNA-guided switches, durable CAR-T, and perioperative EV–pembro—plus 9 trials

## [New in Oncology - Aug 6, 2026](https://sagelyhealth.substack.com/p/new-in-oncology-aug-6-2026)

_2026-08-06 · Oncology Intel by Sagely Health_

Oncology didn’t take a summer vacation: 16 standouts among 66 notable findings—plus 10 trials

## [New in Oncology - July 16, 2026](https://sagelyhealth.substack.com/p/new-in-oncology-july-16-2026)

_2026-07-16 · Oncology Intel by Sagely Health_

Precision medicine keeps winning: adjuvant RET therapy, first-line BRAF CRC, personalized melanoma vaccines, menin AML, and brain metastasis radiation breakthroughs—plus 15 new trials.

## [DOUBLE ISSUE: New in Oncology - July 8, 2026](https://sagelyhealth.substack.com/p/double-issue-new-in-oncology-july)

_2026-07-08 · Oncology Intel by Sagely Health_

ASCO’s long tail keeps delivering in this massive issue: RCC immunotherapy, myeloma CAR-T, AML triplets, PDAC combinations, bladder ADCs, CRC bispecifics, and KRAS T-cell targeting—plus 14 new trials.

## [New in Oncology - June 25, 2026](https://sagelyhealth.substack.com/p/new-in-oncology-june-25-2026)

_2026-06-25 · Oncology Intel by Sagely Health_

ASCO aftershocks keep rolling: melanoma vaccines, MSI-H colon de-escalation, HER2 gastric survival, bladder ADCs, prostate intensification, and head-and-neck IO boosts—plus 32 new trials.

## [New in Oncology - June 18, 2026](https://sagelyhealth.substack.com/p/new-in-oncology-june-18-2026)

_2026-06-18 · Oncology Intel by Sagely Health_

Breast cancer takes center stage this week: HER2 durability, smarter endocrine resistance, and ADCs reshaping TNBC—plus 29 new trials.

## [New in Oncology - June 11, 2026](https://sagelyhealth.substack.com/p/new-in-oncology-june-11-2026)

_2026-06-11 · Oncology Intel by Sagely Health_

The ASCO NSCLC flood is here: 42 notable lung-cancer findings, 7 worth spotlighting first—plus 20 new trials.

## [New in Oncology - June 4, 2026](https://sagelyhealth.substack.com/p/new-in-oncology-june-4-2026)

_2026-06-04 · Oncology Intel by Sagely Health_

KRAS lung cancer strategies break through, EV+pembro shows a bladder survival tail, and ADC+IO raises the bar in frontline TNBC—plus 25 new trials.

## [New in Oncology - May 28, 2026](https://sagelyhealth.substack.com/p/new-in-oncology-may-28-2026)

_2026-05-27 · Oncology Intel by Sagely Health_

Dose-painting GBM, knife-free kidney ablation, a microbiome lift in lung cancer, and HER2 ADC activity across gynecologic tumors—plus 33 new trials

## [8.1% APY Plus Free Stock (Sponsored)](https://crawlproof.com/a/xb27Fh8ZCw7N)

_2026-05-27 · **Sponsored**_

Claim 8.1% APY and up to $1,030 in SK hynix and Nvidia stock.

## [New in Oncology - May 21, 2026](https://sagelyhealth.substack.com/p/new-in-oncology-may-21-2026)

_2026-05-21 · Oncology Intel by Sagely Health_

Targeting gets more precise: rare HER2-low salivary responses, surgery-sparing facial SCC, broad RAS control in PDAC, and CLDN18.2 gastric gains—plus 15 new trials.